Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials.
Stefano AstorinoPaolo AstorrePaola PasquiniDonato Di NunnoFederico PellegriniGiovanni PaolinoPublished in: Dermatologic therapy (2018)